Trumpeter Awards Dinner
Celebrating Consumer Champions in the 21st century
The trumpet is not a quiet instrument. It is used to sound warnings, to mark celebrations, and to announce the presence of special people.
For more than 45 years, the Trumpeter Award has recognized leaders who are not afraid to speak out for social justice and for the rights of consumers.
Trumpeter Award
The Honorable Kathleen Sebelius
Former Secretary of Health and Human Services / Former Governor of Kansas
Florence Kelley Award
Fraidy Reiss
Founding Executive Director, Unchained at Last
Master of Ceremonies
Susan Hogan
News4 Consumer Investigative Reporter
GALLERY
TRUMPETER 2023 AWARDS
Trumpeter Awards 2023
Trumpeter Awards 2022
Trumpeter Awards 2021
Sponsorship info
Support NCL’s mission by sponsoring the 2023 Trumpeter Awards
Trumpeter sponsorships support the work of NCL year-round and allow it to remain a leading voice for consumers and workers. We invite you to join a wide array of businesses, allies, and advocacy organizations in honoring our awardees and helping NCL fight for consumers through public education, policy advocacy, and research.
Sponsors receive tickets to the event and public recognition. Click here for information about sponsorship benefits.
For questions about sponsorship, please contact Karen Silberstein at (202) 207-2825 or karens@nclnet.org.
Trumpeter Award
Dr. Fancis Collins, M.D,, Ph.D
Acting Science Advisor to the president / Former Director, NH
Trumpeter Award
Dr. Fancis Collins, M.D,, Ph.D
Acting Science Advisor to the president / Former Director, NH
Trumpeter Award
Dr. Fancis Collins, M.D,, Ph.D
Acting Science Advisor to the president / Former Director, NH
Trumpeter Award
Dr. Fancis Collins, M.D,, Ph.D
Acting Science Advisor to the president / Former Director, NH
View a complete list of past Trumpeter and Florence Kelley Consumer Leadership awardees.
Benefactor
Consumer Champion
Consumer Advocate
Friend of NCL
Purchase individual tickets
The 20 latest Blog Posts
- Getting a ticket to the U.S. Open: My story
- Labor Day’s dark reality: The alarming rise in child labor in America
- NCL among one of many organizations expressing concern for the growing catalytic converter theft problem
- Food fight: NCL lauds VP Harris’s push for fair grocery pricing amidst corporate greed
- NCL mourns the passing of Congressman Bill Pascrell
- NCL and the National Council on Aging worked with health leaders and obesity specialists to establish a set of rights for people with obesity.
- Family seating rules are a victory for passenger rights
- NCL welcomes bill to curb child labor and other worker abuses
- Guest blog: NCL encourages FTC to propose new rule regarding protections for franchisees in response to exclusion from the agency’s non-compete covenants
- Guest blog: My background in farmwork
- PBMs are driving the increase in out-of-pocket healthcare costs for consumers, says NCL
- NCL sues Washington Nationals over junk fees not disclosed in advertised prices
- Chaotic evacuation of American Airlines Flight 2045 shows urgent need for updated evacuation standards and minimum seat sizes
- Understanding the transformative potential of the Juneteenth holiday
- NCL statement on FTC interim report on PBMs
- NCL’s Child Labor Coalition praises the Biden Administration’s proposed rule to protect indoor and outdoor workers from extreme heat
- What we need now isn’t just abortion access; it’s time for a reproductive justice framework
- Guest blog: Kids and car safety
- NCL staff attends consumer protection brownbag
- NCL submits letter to CDC urging them to make flu and COVID vaccines available at same time
Available Pages
- 125th Anniversary Tribute Book Sponsorship Message
- 125th Anniversary Tribute Book Sponsorship Message – Form Submission
- 2016 Republican National Convention
- 2019 Health Advisory Council Member list
- 2024 AAPD ADA Celebration
- 2024 Democratic National Convention
- 2024 NATIONAL LIFESMARTS CHAMPIONSHIP
- 42nd Annual Gourmet
- 52 Years Consumer Action a celebration of service
- About NCL
- About Us
- Anna Werner
- Annual Report
- Annual Reports
- Annual Spring Soirée 2024
- AOG
- BIOSIMILARS IN 2023
- BIOSIMILARS IN 2023
- Blog
- Board Retreat
- Cannabis
- Careers
- Child Labor Panel & Film Screening
- Child Labor Coalition
- Consumer Action 51st Nov 16
- Consumer Education
- Consumer Education
- Consumer Education Sidebar
- Consumer Protection
- Consumer Protection
- Consumer Protection New
- Consumer Protection Sidebar
- Contact
- copay assistance
- COVID – 19
- Dec. 08 | Consumer Federation of America
- demo
- Donate
- Fair Labor Nov 16
- Fall Fraud.org Forum meeting Invitation
- Featured Program
- Financials
- Food & Nutrition
- Food & Nutrition
- Food & Nutrition Sidebar
- Fraidy Reiss
- Fraud Org
- Fraud org spring event
- Fraud Prevention
- Fraud Prevention
- Fraud Prevention sidebar
- Fraud.org Forum
- Free the Slaves
- Friends of Cancer Research
- georgetown law
- Get the facts on the COVID-19 vaccine
- Girls Inc.
- Global Labor Justice- International Labor Rights Forum (GLJ-ILRF)
- HAC
- HAC 2023
- HAC Meeting on June 12 2023
- Health
- Health
- Health
- Health Advisory Council
- Health Advisory Council Member list
- Health Advisory Council Member Updates
- Health Advisory Council Newsletter
- Health Advisory Council Newsletter
- Health Advisory Council Newsletter | 2018 Q3
- Health Advisory Council Newsletter | 2018 Q3 |
- Health Advisory Council Newsletter | Fall 2020
- Health Advisory Council Newsletter | Fall 2020 | Member Spotlight
- Health Advisory Council Newsletter | Fall 2020 | Member Spotlight
- Health Advisory Council Newsletter | Fall 2020 | Member Updates
- Health Advisory Council Newsletter | Fall 2020 | NCL health policy updates
- Health Advisory Council Newsletter | Fall 2020 | New staff Q&A
- Health Advisory Council Newsletter | Fall 2021 | Health Policy Updates
- Health Advisory Council Newsletter | Fall 2021 | Home
- Health Advisory Council Newsletter | Fall 2021 | Meet NCL Health Policy Associate Milena Berhane
- Health Advisory Council Newsletter | Fall 2021 | Member spotlight
- Health Advisory Council Newsletter | Fall 2021 | Member Updates
- Health Advisory Council Newsletter | Fall 2022
- Health Advisory Council Newsletter | Fall 2022 | Health Policy Updates
- Health Advisory Council Newsletter | Fall 2022 | Member spotlight
- Health Advisory Council Newsletter | Fall 2022 | Member Updates
- Health Advisory Council Newsletter | Meeting Summary | Winter 2021
- Health Advisory Council Newsletter | Spring 2021 | Health Policy Updates
- Health Advisory Council Newsletter | Spring 2021 | home
- Health Advisory Council Newsletter | Spring 2021 | Member spotlight
- Health Advisory Council Newsletter | Spring 2021 | Member Updates
- Health Advisory Council Newsletter | Spring 2022
- Health Advisory Council Newsletter | Spring 2022 | Health Policy Updates
- Health Advisory Council Newsletter | Spring 2022 | Member spotlight
- Health Advisory Council Newsletter | Spring 2022 | Member Updates
- Health Advisory Council Newsletter | Summer 2021 | Health Policy Updates
- Health Advisory Council Newsletter | Summer 2021 | Home
- Health Advisory Council Newsletter | Summer 2021 | June meeting summary
- Health Advisory Council Newsletter | Summer 2021 | Member spotlight
- Health Advisory Council Newsletter | Summer 2021 | Member Updates
- Health Advisory Council Newsletter | Summer 2023
- Health Advisory Council Newsletter | Summer 2023 | Health Policy Updates
- Health Advisory Council Newsletter | Summer 2023 | Member spotlight
- Health Advisory Council Newsletter | Summer 2023 | Member Updates
- Health Advisory Council Newsletter | Winter 2021
- Health Advisory Council Newsletter | Winter 2021 | Member Spotlight
- Health Advisory Council Newsletter | Winter 2021 | Member Updates
- Health Advisory Council Newsletter | Winter 2021 | NCL health policy updates
- Health Advisory Council Newsletter | Winter 2022 | December meeting summary
- Health Advisory Council Newsletter | Winter 2022 | Health Policy Updates
- Health Advisory Council Newsletter | Winter 2022 | Home
- Health Advisory Council Newsletter | Winter 2022 | Member spotlight
- Health Advisory Council Newsletter | Winter 2022 | Member Updates
- Health Advisory Council Spring 2024 Membership Meeting
- Health Advisory Council Winter Meeting
- Health Sidebar
- HIPAA Summit
- History
- Home
- Home-Demo
- Human Trafficking Legal Center
- IGBA
- Janssen
- Kathleen Sebelius
- Keeping up with Sally & Staff
- Kelley Drye
- Lael Brainard
- Latest Bulletin
- Leadership
- Legal Work
- Letter in support of SALSA Act
- LifeSmarts
- lifesmarts 29th nationals
- Lifesmarts Spring Soiree 2024
- LUNCH BRIEFING
- Martin Luther King
- Media
- Media Contacts
- Menopause Advocacy Coalition meeting at FDA
- Mission
- National Consumer Protection Week Hill Reception
- National Counsel on Aging Town Hall
- NCL CEO urges Congress to end companies’ addiction to junk fees
- NCL health policy updates
- NCL health policy updates | Health Advisory Council Newsletter | 2018 Q3
- NCL in the News
- News & Highlights
- Newsletter
- Newsletter Signup
- Newsroom
- OFW Nov.8 2023
- One Fair Wage event
- One Fair Wage Mayors for Livable Wages Event-January 19-2024
- otc hearing aids
- Other NCL Positions
- Our Impact
- Our Programs
- Our Work
- Our Work new
- Our Work new
- Partner Logos
- Partner With Us
- Partnering with FICO
- pbms
- Podcast
- Press Releases
- Preterm Birth Prevention Alliance.
- Preterm Birth Prevention Alliance.
- Privacy Policy
- Protecting Consumers from Hidden Junk Fees
- Public Citizen 50
- Purchase individual tickets
- Rob Bonta
- Saru Jayaraman
- saving black lives
- ScamBulance
- Script Your Future
- Sign Up
- sllider
- Solar eclipse 2024
- Sponsorship Deck 2023
- Spring Soirée
- Spring Soirée 2023
- Stanford Biodesign Policy Program Health Technology Innovation Policy Conference 2024
- Take Action
- the Consumer Federation of America’s fifty-first awards ceremony.
- The Eaton
- The Hill
- The Path Forward for a Safe Cannabis Marketplace
- Ticketing 101
- Tik Tok
- Trumpeter 2022
- Trumpeter Awards | 2021 Sponsors
- Trumpeter Awards | 2022 Sponsors
- Trumpeter Awards 2022
- Trumpeter Awards 2022
- Trumpeter Awards 2023
- Trumpeter Awards 2023 copy
- Trumpeter Awards 2023 old 06-06-2023
- Trumpeter Awards 2024
- Trumpeter Awards winners old
- Trumpeter Sponsorship – Form Submission
- Trumpeter Sponsorship Form
- Unchained at Last – Work to end forced and child marriage
- Utah Law event
- Virtual Food Issues Forum | February 24, 2021
- Where We Stand
- Where We Stand New
- Women in Government panel in Orlando Nov 18
- Workers Rights
- Workers Rights
- Workers’ Rights Sidebar
Archives by Subject:
- Blog
- Blog, health
- Blogs, food
- CBD
- Child labor
- Compensation / Wages
- Consumer Education
- Consumer literacy
- Consumer policy
- Consumer Protection
- Coronavirus
- Corporate social responsibility
- Diseases and treatment
- Education
- Environment
- Featured Home – Consumer Education
- Featured Home – Consumer Protection
- Featured Home – Food & Nutrition
- Featured Home – Fraud Prevention
- Featured Home – Workers Rights
- Featured Home – Your Health
- Food
- Food & Nutrition
- Food policy
- Food safety
- Food waste
- Fraud policy
- Fraud Prevention
- Health
- Health policy
- Healthcare coverage
- ID theft
- imported
- Insurance
- Labeling
- Labor
- Labor policy
- LifeSmarts
- Medication adherence
- Nutrition
- Personal finance
- Podcast
- Press release
- Press releases, health
- Prevention
- Privacy & security
- Psychoanalytic Assocation News
- Safety
- Scams
- Statement
- Technology
- Teens
- Telecommunications
- Transportation
- Uncategorized
- Workers' Rights
- Workplace safety
Archives by Month:
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- February 2007
- January 2007
- May 2006
- March 2006
- February 2006
- October 2005
- March 2002
- January 2002
- February 2001
- November 2000
- February 2000
Our Impact
The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.
Read about NCL’s impact
Preventing yet another victim
Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.
Read about NCL’s impact
Building a stronger generation
A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.
Read about NCL’s impact
Script Your Future saved my life
Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.
Read about NCL’s impact
For a safer workplace
Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.
Read about NCL’s impact
[gravityform id=”11″ title=”true” description=”false”]
[gravityform id=”9″ title=”true” description=”false” ajax=”true”]
PBPA Commends HHS Funding to Support Maternal and Infant Health
The Preterm Birth Prevention Alliance (PBPA), a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, applauds the U.S. Department of Health and Human Services (HHS) for awarding nearly $350 million to states across the country to improve support for safe pregnancies and healthy babies.
“For far too long, U.S. maternal health care has lagged behind that of other developed countries, particularly for women of color,” noted Sally Greenberg, Executive Director of the National Consumers League. “This additional funding will enable local health departments and nonprofits to better address the health care needs of the most vulnerable mothers and their babies.”
The funding, awarded by HHS’ Health Resources and Services Administration (HRSA), will support home visiting services, increase access to doulas, address infant mortality and maternal illness, and improve data reporting on maternal mortality.
“Maternal health care in the U.S. has consistently failed women of color,” Greenberg continued. “We applaud HHS for this additional funding that will help to improve the maternal health for all mothers and babies, especially women of color and those most at-risk.”
The funding announcement follows the release of a report by the U.S. Commission on Civil Rights which found that Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. This disparity was further exacerbated for Black women in the U.S., who are three to four times more likely to die from pregnancy-related complications than white women.
“In addition to expanding programs to support maternal health, we must increase representation from racially and ethnically diverse groups in research and clinical trials, particularly those studying treatment options to prevent maternal morbidity and mortality,” said Greenberg. “The need for the additional HHS funding and the report from the Commission on Civil Rights clearly illustrate how critical representative research and real world evidence are to ensuring all mothers and their babies have the same opportunity for the best possible health outcomes.”
Diverse research for a diverse America: The value of equitable, real-world research
/in Blog, Health, Prevention Blog Post
By Sally Greenberg, NCL Executive Director
While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.
The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.
Existing efforts to improve inclusion
Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.
Recognizing the potential for RWE in maternal health
The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.
Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.
Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.
The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.
PRETERM BIRTH PREVENTION ALLIANCE APPLAUDS FDA’S GRANTING OF HEARING FOR THE ONLY FDA-APPROVED THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, August 26, 2021 –
Preterm Birth Prevention Alliance a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, commends the U.S. Food and Drug Administration (FDA) for granting a public hearing to discuss 17P, the only FDA-approved class of branded and generic treatments to reduce preterm birth in indicated patients.
We appreciate the FDA’s willingness to hear directly from individuals facing prematurity and the providers who treat them about their experiences with 17P,” said National Consumer League’s Executive Director Sally Greenberg. “It is an important step towards better understanding variations in efficacy across diverse populations and ensuring all women have an equal chance at the best possible outcomes.”
Last week, the FDA agreed to grant Covis Pharma, the manufacturer of the branded 17P product Makena its request for a public hearing to discuss 17P. Hydroxyprogesterone caproate—or “17P”—has been approved since 2011 and is the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth in the United States. In 2020, the FDA proposed withdrawing 17P in all its forms, including the branded product and its five generic versions, based on conflicting efficacy data from two studies composed of vastly different populations, one predominantly inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“Mothers and birthing people deserve access to the best possible treatments to prevent preterm birth. We cannot achieve birth equity if we study pregnant women as a monolith,” said Blythe Thomas, Initiative Director of 1,000 Days. “It is only by systematically researching the real-world, post-market impact of 17P on individuals from a variety of racial and ethnic backgrounds, while maintaining access for all affected, that we can reduce disparities in maternal and infant health.”
While the hearing date has not yet been set, the Alliance looks forward to sharing the perspectives of affected individuals and their physicians with the agency once the hearing is scheduled and will continue to advocate for at-risk moms and babies of all races and ethnicities.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance (PBPA) is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, the 15 partners in the PBPA seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org
LEADING PATIENT ADVOCATES LAUNCH PRETERM BIRTH PREVENTION ALLIANCE TO PROTECT CRITICAL ACCESS TO THE SOLE FDA-APPROVED CLASS OF THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, April 20, 2021 – Today, the National Consumers League (NCL), along with a coalition of patient advocacy organizations dedicated to advancing the health of mothers and infants, announced the launch of the >Preterm Birth Prevention Alliance.
Members of the Alliance are joining forces in an effort to preserve patient access to the only Food & Drug Administration-approved class of treatments for pregnant women who have previously had an unexpected, or spontaneous, preterm birth. Together, Alliance members seek to ensure that the Food & Drug Administration (FDA) hears concerns from the full range of stakeholders about the potential risks and impact of withdrawal for at-risk pregnant women and their providers.
For the fifth year in a row, the U.S. preterm birth rate has increased (to 10.2 percent of births), and preterm birth and its complications were the second largest contributor to infant death across the country. Preterm birth also represents a significant racial health disparity, with Black women in America experiencing premature delivery at a rate 50 percent higher than other racial groups throughout the country.
However, in 2020, the FDA >proposed withdrawing hydroxyprogesterone caproate, commonly called “17P” or “17-OHPC”, the only FDA-approved class of branded and generic treatments to help prevent the risk of preterm birth in women with a history of spontaneous preterm birth. The FDA is currently determining whether to hold a hearing on the status of 17P, based on conflicting efficacy data from two studies composed of vastly different patient populations, one inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“We’re fighting for a more inclusive healthcare system that gives everyone an equal chance to have the best outcomes possible,” said Sally Greenberg, executive director of the National Consumers League. “We don’t believe that removing 17P from the market without gaining a better understanding of who could benefit the most from its use is in the best interests of patients, nor their healthcare providers, particularly as there are no other approved treatment options available.”
To date, 14 organizations have joined NCL to advocate for the health interests of at-risk pregnant women and infants, including: 1,000 Days; 2020 Mom; American Association of Birth Centers; Black Mamas Matter Alliance; Black Women’s Health Imperative; Expecting Health; Healthy Mothers, Healthy Babies Montana; HealthyWomen; Miracle Babies; National Birth Equity Collaborative; National Black Midwives Alliance; National Partnership for Women & Families; Sidelines High-Risk National Support Network; and SisterReach.
“As a trained obstetrician and gynecologist, I know firsthand the impact of preterm birth on Black women and birthing people. I also know that racism – not race – is the driving factor leading the disproportionate impact of preterm birth on Black women and birthing people thereby exacerbating systemic inequities in maternal and infant health. To achieve birth equity, which is the assurance of the conditions of optimal births for all people with a willingness to address racial and social inequities in a sustained effort, we must work to protect and uphold a standard of care for spontaneous, recurrent preterm births and ensure it remains accessible and affordable for all who stand in need,” added Dr. Joia Crear Perry, founder and president of the National Birth Equity Collaborative.
The Preterm Birth Prevention Alliance is calling for the FDA to grant a public hearing to fully consider all of the data, additional research methods, and stakeholder perspectives before deciding whether to withdraw approval of this critical class of therapies. The health of America’s moms and babies warrants the utmost care and consideration.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, we seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org.
Initial support for the Preterm Birth Prevention Alliance is provided by Covis Pharma.
MEDIA CONTACT:
Carol McKay, carolm@nclnet.org
<embed src=”https://art19.com/shows/ce489618-5918-423a-9b5f-35ce4c28ca09/episodes/2f8fa6fc-6aad-4f1f-bf13-3bdb0aa41732/embed?theme=light-custom&primary_color=%231850a3″ width=”100%” height=”300″></embed>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/c7b22520-c0aa-4718-9b59-4ee67e494547/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ab80228e-48d9-4a45-a894-a1bfc4e41c64/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ea08cbc0-f9f2-4082-9222-4e33f68b6826/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/5039453f-6008-413a-9f6b-c9be649fd26e/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/fafb46f8-6d90-4cd8-91be-616366d1b8ca/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/25f0485d-bbce-46c8-bb90-139dcf1a2e7b/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ffbcae35-84c5-4c8b-9686-6e2c79679dd0/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/520bdd73-d142-4508-9706-d81b5c042dff/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/12354e8b-bf15-4eba-b34f-20e435df3bb7/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/e2091efc-d66d-49f4-aa8e-8e6249858310/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>